Cathie Wood Crispr Therapeutics Ag Transaction History
Ark Investment Management LLC
- $11.4 Billion
- Q4 2024
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Ark Investment Management LLC holds 8,973,064 shares of CRSP stock, worth $476 Million. This represents 3.09% of its overall portfolio holdings.
Number of Shares
8,973,064
Previous 7,498,625
19.66%
Holding current value
$476 Million
Previous $352 Million
0.23%
% of portfolio
3.09%
Previous 3.35%
Shares
31 transactions
Others Institutions Holding CRSP
# of Institutions
483Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Capital International Investors Los Angeles, CA8.74MShares$464 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$202 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$147 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$146 Million0.07% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$146 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.14B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....